These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952 [TBL] [Abstract][Full Text] [Related]
52. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Marson A; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton C; Hughes DA; Williamson P; Baker GA; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE; Lancet; 2021 Apr; 397(10282):1375-1386. PubMed ID: 33838758 [TBL] [Abstract][Full Text] [Related]
53. Leg cramps. Young G BMJ Clin Evid; 2015 May; 2015():. PubMed ID: 25970567 [TBL] [Abstract][Full Text] [Related]